Malignant Mesothelioma: Clinical, Pathological and Radiological Findings

被引:1
作者
Sapmaz, Feride [1 ]
Lakadamyali, Hseyin [2 ]
Katrancioglu, Ozgur [3 ]
Yildirim, Yesim [4 ]
Dongel, Isa [3 ]
机构
[1] Baskent Univ Alanya Arastirma & Uygulama Merkezi, Gogus Cerrahisi AD, TR-07400 Alanya, Antalya, Turkey
[2] Baskent Univ Alanya Arastirma & Uygulama Merkezi, Gogus Hastaliklari AD, Alanya, Turkey
[3] Gogus Cerrahisi Klin, Sivas Numune Hastanesi, Sivas, Turkey
[4] Tibbi Onkoloji Bolumu, Acibadem Kozyatagi Hastanesi, Istanbul, Turkey
关键词
Malignant Pleural Mesothelioma; Pathology; Radiology; Mortality;
D O I
10.4328/JCAM.544
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Malignant pleural mesothelioma is a tumor of locally invasive character and of fatal course, frequently arising following asbest exposure. In the present study we attempted to retrospectively evaluate the clinical, pathological, and radiological findings of 27 cases diagnosed with MPM. Material and Method: 27 cases diagnosed with MPM in our medical facility have been included into the study, 14 females, and 13 males. Of the cases, 4 have been diagnosed based on transthoracic pleural biopsy, and 23 - using surgical methods (VYTC, thoracotomy). Result: Radiological evaluation revealed pleural thickening in 23 (85.2%), pleural effusion in 20 (74.1%), volume loss in 15 (55.6%), pleural nodulation in 14 (51.9%), mediastinal shift in 4 (14.8%), pneumothorax in 1 (3.7%), and hydropneumothorax in 1 (3.7%) of the cases, respectively. Histopathological examination failed to reveal any typing in 17 (63%) of the cases. On the other hand, 5 (18.5%) of the remainder cases were of the epitheloid type, 4 (14.8%) were of the sarcomatoid type, and 1 (3.7%) was of the biphasic MPM type. Mean survival rate of the 3 (11.1%) Stage I cases was 1449 days, of the 6 (22.2%) Stage II cases was 480 days, of the 18 (66.7%) Stage III cases was 214 days. We had no Stage IV cases at the time of diagnosis. A statistically significant difference has been established between the Stage and the mean survival rate of the cases. Discussion: In diagnosing MPM, proper histopathological exam followed by proper radiological staging should be carried out. A multimodality approach comprises the present MPM treatment, but total cure cannot be provided.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 32 条
[1]  
Adachi Y, 2010, ANTICANCER RES, V30, P1947
[2]  
Albelda S M, 1998, FISHMANS PULMONARY D, P1453
[3]  
Basibuyuk Z, SIVAS BOLGESI OFIYOL, P11
[4]   Malignant pleural mesothelioma [J].
Boutin, C ;
Schlesser, M ;
Frenay, C ;
Astoul, P .
EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (04) :972-981
[5]  
BOUTIN C, 1991, CANCER, V67, P2033, DOI 10.1002/1097-0142(19910415)67:8<2033::AID-CNCR2820670804>3.0.CO
[6]  
2-8
[7]   Intrapleural streptokinase in the management of malignant multiloculated pleural effusions [J].
Davies, CWH ;
Traill, ZC ;
Gleeson, FV ;
Davies, RJO .
CHEST, 1999, 115 (03) :729-733
[8]   Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma [J].
de Bree, E ;
van Ruth, S ;
Baas, P ;
Rutgers, EJT ;
van Zandwijk, N ;
Witkamp, AJ ;
Zoetmulder, FAN .
CHEST, 2002, 121 (02) :480-487
[9]  
De Rienzo A, 2002, J CELL BIOCHEM, V84, P455, DOI 10.1002/jcb.10058.abs
[10]   The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the American Joint Committee on Cancer staging system [J].
Flores, Raja M. ;
Routledge, Tom ;
Seshan, Venkatraman E. ;
Dycoco, Joseph ;
Zakowski, Maureen ;
Hirth, Yael ;
Rusch, Valerie W. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 136 (03) :605-610